# Endurant Evo International Clinical Trial

> **NCT02461524** · NA · TERMINATED · sponsor: **Medtronic Cardiovascular** · enrollment: 69 (actual)

## Conditions studied

- Abdominal Aortic Aneurysm
- AAA

## Interventions

- **DEVICE:** Endurant Evo AAA Stent Graft System
- **PROCEDURE:** Endovascular aneurysm repair (EVAR)

## Key facts

- **NCT ID:** NCT02461524
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2021-06-25
- **Final completion:** 2021-06-25
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** This study terminated enrollment due to device failures prior to enrollment completion.
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461524, "Endurant Evo International Clinical Trial". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02461524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*